Azithromycin Treatment for SARS-CoV-2-related COVID-19 Pandemic Could Worsen Extensively Drug Resistant (XDR) Typhoid: A Risk of Losing the Last Bullet Against <i>Salmonella enterica</i> Serovar <i>Typhi</i>
| Author | Umar Saeed | en |
| Author | Sara Rizwan Uppal | en |
| Author | Zahra Zahid Piracha | en |
| Author | Rizwan Uppal | en |
| Issued Date | 2021-01-31 | en |
| Abstract | This article does not have an abstract. | en |
| DOI | https://doi.org/10.5812/jjm.113874 | en |
| Keyword | COVID-19 | en |
| Keyword | SARS-CoV-2 | en |
| Keyword | Extensively Drug Resistant (XDR) Typhoid | en |
| Keyword | <i>Salmonella enterica</i> Serovar <i>Typhi</i> | en |
| Publisher | Brieflands | en |
| Title | Azithromycin Treatment for SARS-CoV-2-related COVID-19 Pandemic Could Worsen Extensively Drug Resistant (XDR) Typhoid: A Risk of Losing the Last Bullet Against <i>Salmonella enterica</i> Serovar <i>Typhi</i> | en |
| Type | Letter | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jjm-14-1-113874.pdf
- Size:
- 87.76 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF